# Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy

> **NCT01869218** · — · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 40 (actual)

## Conditions studied

- Hematologic Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01869218
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-02
- **Primary completion:** 2015-08-03
- **Final completion:** 2021-01-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01869218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01869218, "Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01869218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*